Zobrazeno 1 - 10
of 106
pro vyhledávání: '"W. G. V. Quint"'
Autor:
H J C de Vries, Edyta C. Pirog, M.F. Schim van der Loeff, David G. Jenkins, A van Eeden, John Doorbar, W. G. V. Quint, M.M. van de Sandt, E Marra, M. van Zummeren, Annemiek Leeman, Chris J.L.M. Meijer, F. J. van Kemenade
Publikováno v:
British journal of dermatology, 182(4), 1026-1033. Wiley-Blackwell
Leeman, A, Jenkins, D, Marra, E, van Zummeren, M, Pirog, E C, van de Sandt, M M, van Eeden, A, Schim van der Loeff, M F, Doorbar, J, de Vries, H J C, van Kemenade, F J, Meijer, C J L M & Quint, W G V 2020, ' Grading immunohistochemical markers p16INK4a and HPV E4 identifies productive and transforming lesions caused by low-and high-risk HPV within high-grade anal squamous intraepithelial lesions ', British Journal of Dermatology, vol. 182, no. 4, pp. 1026-1033 . https://doi.org/10.1111/bjd.18342
The British journal of dermatology, 182(4), 1026-1033. Wiley-Blackwell Publishing Ltd
British Journal of Dermatology, 182(4), 1026-1033. Wiley-Blackwell
The British Journal of Dermatology
Leeman, A, Jenkins, D, Marra, E, van Zummeren, M, Pirog, E C, van de Sandt, M M, van Eeden, A, Schim van der Loeff, M F, Doorbar, J, de Vries, H J C, van Kemenade, F J, Meijer, C J L M & Quint, W G V 2020, ' Grading immunohistochemical markers p16INK4a and HPV E4 identifies productive and transforming lesions caused by low-and high-risk HPV within high-grade anal squamous intraepithelial lesions ', British Journal of Dermatology, vol. 182, no. 4, pp. 1026-1033 . https://doi.org/10.1111/bjd.18342
The British journal of dermatology, 182(4), 1026-1033. Wiley-Blackwell Publishing Ltd
British Journal of Dermatology, 182(4), 1026-1033. Wiley-Blackwell
The British Journal of Dermatology
OBJECTIVES: Because current guidelines recognise high-grade anal squamous intraepithelial lesions (HSILs) and low-grade SILs (LSILs), and recommend treatment of all HSILs although not all progress to cancer, this study aims to distinguish transformin
Autor:
Agata Rodriguez, M del Pino, David G. Jenkins, Annemiek Leeman, W. G. V. Quint, M. de Koning, Jaume Ordi, Aureli Torné, Anco Molijn, F. J. van Kemenade
Publikováno v:
Bjog-An International Journal of Obstetrics and Gynaecology, 124(9), 1356-1363. Wiley-Blackwell Publishing Ltd
Objective To compare the sensitivity of high-risk human papillomavirus (hrHPV) and genotype detection in self-collected urine samples in the morning (U1), and later on (U2), brush-based self-samples (SS), and clinician-taken smears (CTS) for detectin
Autor:
Andries J. Hoitsma, J.A. de Hullu, Willem J. G. Melchers, Leon F.A.G. Massuger, Luuk B. Hilbrands, W. G. V. Quint, Joanna IntHout, K.A.P. Meeuwis, F. Hinten
Publikováno v:
American Journal of Transplantation, 17, 1563-1573
American Journal of Transplantation, 17, 6, pp. 1563-1573
American Journal of Transplantation, 17, 6, pp. 1563-1573
Contains fulltext : 174161.pdf (Publisher’s version ) (Closed access) Female renal transplant recipients (RTRs) have an increased risk for developing human papillomavirus (HPV)-related (pre)malignant lesions of the genital tract. This study aims to
Autor:
Marc Arbyn, W. G. V. Quint, M.N.C. de Koning, L. van Doorn, Kate Cuschieri, D.T. Geraets, Peter J.F. Snijders, Chris J.L.M. Meijer
Publikováno v:
Geraets, D T, Cuschieri, K, de Koning, M N C, van Doorn, L J, Snijders, P J F, Meijer, C J L M, Quint, W G V & Arbyn, M 2014, ' Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control ', Journal of Clinical Microbiology, vol. 52, no. 11, pp. 3996-4002 . https://doi.org/10.1128/JCM.01962-14
Geraets, D T, Cuschieri, K, de Koning, M N C, van Doorn, L J, Snijders, P J F, Meijer, C J L M, Quint, W G V & Arbyn, M 2014, ' Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control ', Journal of Clinical Microbiology, vol. 58, no. 11, pp. 3996-4002 . https://doi.org/10.1128/JCM.01962-14
Journal of Clinical Microbiology, 58(11), 3996-4002. American Society for Microbiology
Geraets, D T, Cuschieri, K, de Koning, M N C, van Doorn, L J, Snijders, P J F, Meijer, C J L M, Quint, W G V & Arbyn, M 2014, ' Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control ', Journal of Clinical Microbiology, vol. 58, no. 11, pp. 3996-4002 . https://doi.org/10.1128/JCM.01962-14
Journal of Clinical Microbiology, 58(11), 3996-4002. American Society for Microbiology
The LMNX genotyping kit HPV GP (LMNX) is based on the clinically validated GP5+/6+ PCR, with a genotyping readout as an alternative for the more established enzyme immunoassay (EIA) detection of 14 targeted high-risk human papillomavirus (HPV) types.
Autor:
Willem J. G. Melchers, Ruud L.M. Bekkers, Charlotte H. Lenselink, J. Berkhof, Birgit I. Witte, Channa E. Schmeink, W. G. V. Quint, Leon F.A.G. Massuger
Publikováno v:
International Journal of Cancer. 133:172-181
Human papillomavirus (HPV) is a necessary factor in the development of cervical intraepithelial neoplasia and cervical cancer. However, HPV is also a very common sexually transmitted virus and many women clear their infection. To study HPV incidence
Autor:
Ruud L.M. Bekkers, B. ter Harmsel, Remko P. Bosgraaf, R. van Baars, W. G. V. Quint, Willem J. G. Melchers
Publikováno v:
Journal of Clinical Microbiology, 50, 3937-43
Journal of Clinical Microbiology, 50, 12, pp. 3937-43
Journal of Clinical Microbiology, 50, 12, pp. 3937-43
Primary screening using high-risk human papillomavirus (hrHPV) detection has been suggested as a way of improving cervical cancer prevention. Women currently not attending screening (nonresponders) are more likely to participate when given the opport
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 81
Background The benefit of HPV testing for cervical cancer screening and disease management has been shown in many recent studies and is part of several new evidence-based guidelines. Assessment of emerging HPV tests in this context is essential, usin
Autor:
Just A.H. Eekhof, W. G. V. Quint, M. Kamp, L.V. Khoe, M.N.C. de Koning, Jacobijn Gussekloo, J. Ter Schegget, J.N. Bouwes Bavinck
Publikováno v:
Journal of Clinical Virology, 52(2), 84-87
Background Large numbers of HPV types infect the human skin and members from the HPV genera alpha, gamma and mu are associated with cutaneous warts. Objectives The aim of this study was to test if the HPV genotypes in swabs of the overlying skin are
Autor:
J.N. Bouwes Bavinck, J. Ter Schegget, W. G. V. Quint, M.N.C. de Koning, Tim Waterboer, Michael Pawlita, Mariet C.W. Feltkamp, M.C.A. Polderman
Publikováno v:
British Journal of Dermatology. 164:771-775
P>Background Recent studies revealed that Betapapillomavirus (betaPV) infections are highly prevalent. Skin diseases such as psoriasis, characterized by keratinocyte hyperproliferation, and atopic dermatitis (AD), dominated by cutaneous inflammation,
Autor:
Ruud L.M. Bekkers, Willem J. G. Melchers, D.T. Geraets, L.J. van Doorn, C.H. Lenselink, W. G. V. Quint
Publikováno v:
Journal of Clinical Virology, 50, 4, pp. 276-80
Journal of Clinical Virology, 50, 276-80
Journal of Clinical Virology, 50, 276-80
Item does not contain fulltext BACKGROUND: High-risk (hr)HPV testing plays an important role in primary cervical cancer screening. Subsequent hrHPV genotyping might contribute to better risk stratification. The majority of hrHPV tests do not include